Effect of Lidocaine Phonophoresis Versus Pulsed Ultrasound on Myofascial Pain Syndrome in Athletic Children

NCT ID: NCT04185194

Last Updated: 2019-12-04

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: PHASE1
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2019-01-01
• Study Completion Date: 2019-03-01

Brief Summary

A topical anesthetic gel lidocaine has been widely used as a local anesthetic to reduce the pain and discomfort. It provides local analgesia by blocking the initiation and transmission of impulses. Lidocaine topical anesthetic gel allows the use of high concentrations of the anesthetic bases without concern about local irritation, uneven absorption or systemic toxicity (Argoff, 2000 ). So, the aim of this study is to compare between the effect of lidocaine phonophoresis and pulsed ultrasound in myofascial pain syndrome in swimmers children.

Detailed Description

Fourty five children (athletic swimmers) participated in this study, and were classified into three groups ; First control group A : this group consisted of fifteen children were receiving traditional physical therapy program. Second study group B: this group consisted of fifteen children were receiving pulsed ultrasound in addition to traditional physical therapy program as the same as in group A. Third study group C: this group consisted of fifteen children were receiving lidocaine phonophoresis in addition to traditional physical therapy program as the same as in group A. Treatment program in the three groups applied three times a week for three successive months. The study was done in the outpatient clinic of Ismailiy Sporting Club, Ismailia, Egypt.

Conditions

Treatment Side Effects

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

group A

received especially designed physical therapy program

Group Type: ACTIVE_COMPARATOR

especially designed physical therapy program

Intervention Type: OTHER

by myofascial trigger point release, stretching and strengthening exercises of upper trapezius muscle and infrared radiation by tungsten lamp for upper trapezius

group b

received pulsed ultrasound in addition to physical therapy program

Group Type: EXPERIMENTAL

Lidocaine

Intervention Type: DRUG

transmission of the drug molecules to the underlying muscles

pulsed ultrasound

Intervention Type: DEVICE

using thermogenic and cavitation effect of ultrasound to reduce tight muscles and relieve pain

especially designed physical therapy program

Intervention Type: OTHER

by myofascial trigger point release, stretching and strengthening exercises of upper trapezius muscle and infrared radiation by tungsten lamp for upper trapezius

group c

received lidocaine phonophoresis in addition to physical therapy program

Group Type: EXPERIMENTAL

Lidocaine

Intervention Type: DRUG

transmission of the drug molecules to the underlying muscles

pulsed ultrasound

Intervention Type: DEVICE

using thermogenic and cavitation effect of ultrasound to reduce tight muscles and relieve pain

especially designed physical therapy program

Intervention Type: OTHER

by myofascial trigger point release, stretching and strengthening exercises of upper trapezius muscle and infrared radiation by tungsten lamp for upper trapezius

Interventions

Lidocaine

transmission of the drug molecules to the underlying muscles

Intervention Type: DRUG

pulsed ultrasound

using thermogenic and cavitation effect of ultrasound to reduce tight muscles and relieve pain

Intervention Type: DEVICE

especially designed physical therapy program

by myofascial trigger point release, stretching and strengthening exercises of upper trapezius muscle and infrared radiation by tungsten lamp for upper trapezius

Intervention Type: OTHER

Other Intervention Names

lidocaine topical

Eligibility Criteria

Inclusion Criteria

• • Age range from 10 to 14 years.

• All children have regional neck pain complaint.
• Tenderness in cervical trigger points in the midpoint of the upper border of trapezius muscle, from grade II to grade IV according to tenderness grading scheme (Hubbard and Berkoff, 1993) (Appendix I ) ● The diagnosis of an active MTrP in the upper trapezius according to (Ardiçet al . , 2002 and Bruno, 2005)

Exclusion Criteria

• • Neurological disorders.

• Dermatological disorders.
• Acute trauma prior to the study.
• Fibromyalgia, systemic disease and drug allergy history were excluded from the study.
• Having myofascial trigger points injection.
• Chronic pain in both sides of the body.

• Minimum Eligible Age: 10 Years
• Maximum Eligible Age: 14 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Cairo University

OTHER

Sponsor Role: lead

Responsible Party

Mohamed abdel Moneim Abo El Roos

pediatric physical therapy specialist (master degree)

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Asser Sallam, PhD

Role: STUDY_DIRECTOR

Suez Canal University

Locations

faculty of physical therapy,Cairo University

Giza, , Egypt

Countries

Egypt

Other Identifiers

P.T.REC/012/001708

Identifier Type: -

Identifier Source: org_study_id